Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Clinical Research in Southampton
Southampton Children's Hospital
A
A
A
Text only
| Accessibility | Privacy and cookies
"Helpful, informative, polite and friendly staff put my mind at ease"
Patient feedback
Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us
You are here:
Home
>
Search results
Search
Browse site A to Z
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Search results
Go To Advanced Search
Search
You could also try:
reply (21)
,
answer (791)
,
reaction (683)
Gilteritinib
Description
Chemotherapy Protocol Acute Myeloid Leukaemia GILTERITINIB Regimen AML - Gilteritinib Indication Gilteritinib for treating rel
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Gilteritinib.pdf
Carboplatin(AUC2)-Paclitaxel (7 day)
Description
A chemotherapy protocol on Carboplatin (AUC2) Paclitaxel.
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC2-Paclitaxel7day.pdf
FoM Research Conference programme - final
Description
Faculty of Medicine Research Conference PROGRAMME Tuesday 14th June 2022 Microsoft Teams TIME EVENT SPEAKER 09.15-09.20 MICROSOFT TEAMS
Url
/Media/Southampton-Clinical-Research/Downloads/FoM-Research-Conference-programme-final.pdf
Craniotomy for brain tumour removal - patient information
Description
A craniotomy is an operation where a disc of bone is removed from the skull using special tools to allow access
Url
/Media/UHS-website-2019/Patientinformation/Brain-and-spine/Craniotomy-for-brain-tumour-removal-1192-PIL.pdf
Ibrutinib (MCL) (560mg)
Description
Chemotherapy Protocol Mantle Cell Lymphoma Regimen Ibrutinib • MCL – Ibrutinib (560mg) Indication • Mantle Cell Lymphoma with cyclin
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Ibrutinib-MCL-560mg.pdf
NilotinibChronic
Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (chronic phase) Regimen • CML – Nilotinib (chronic phase) Indica
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibChronic.pdf
NilotinibAccelerated
Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (accelerated phase) Regimen • CML – Nilotinib (accelerated phase
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibAccelerated.pdf
DasatinibChronic
Description
Chemotherapy Protocol Chronic Myeloid Leukaemia DASATINIB (chronic phase) Funding may be required for specific indications
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/DasatinibChronic.pdf
DasatinibAccelerated
Description
Chemotherapy Protocol Chronic Myeloid Leukaemia DASATINIB (accelerated phase) Funding may be required for specific indica
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/DasatinibAccelerated.pdf
Capecitabine 1250 (14)
Description
Chemotherapy Protocol BREAST CANCER CAPECITABINE 1250 (14 day) Regimen • Breast Cancer – Capecitabine 1250 (14 day) Indication • Treatment of lo
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Capecitabine1250-14.pdf
251
to
260
of
398
Previous
…
24
25
26
27
28
…
Next
Site policies
Report a problem with this page
Privacy and cookies
Site map
Translation
Last updated: 14 September 2019
Contact details
University Hospital Southampton NHS Foundation Trust
Tremona Road
Southampton
Hampshire
SO16 6YD
Telephone: 023 8077 7222
Useful links
Home
Getting here
What to do in an emergency
Research
Working here
Education
© 2014 University Hospital Southampton NHS Foundation Trust
Browser does not support script.
Browser does not support script.